A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The study conducted on cancer patients is designed to test safety and efficacy of limb hypothermia in cancer patients using the new Paxman Limb Cryocompression System (PLCS). Ultimately this will lead to the development of a therapy regime that will help to prevent chemotherapy-induced neuropathy in cancer patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 80
Healthy Volunteers: f
View:
• Age 21- 80 years.
• Signed informed consent from patient or legal representative
• Scheduled to receive weekly paclitaxel chemotherapy
• Patients may receive other chemotherapy drugs alongside taxane e.g. Platinum/Herceptin.
Locations
Other Locations
Singapore
Curie Oncology, Mount Elizabeth Novena Specialist Centre
NOT_YET_RECRUITING
Singapore
National University Hospital
RECRUITING
Singapore
Contact Information
Primary
Si Jing, Joline Lim
joline_sj_lim@nuhs.edu.sg
6773 7888
Backup
Aishwarya Bandla
aishwarya.bandla@nus.edu.sg
Time Frame
Start Date: 2022-11-11
Estimated Completion Date: 2026-11
Participants
Target number of participants: 80
Treatments
Experimental: Cancer patients
Cancer patients will undergo limb cryocompression based on the established optimal temperature and pressure from previous studies over multiple cycles of chemotherapy to establish safety and tolerability of repeated therapy.
Related Therapeutic Areas
Sponsors
Collaborators: The N.1 Institute for Health, National University of Singapore, Paxman Coolers Ltd., Curie Oncology, Mount Elizabeth Novena Specialist Centre
Leads: National University Hospital, Singapore